BENEFICIAL ROLE OF HERBAL HEPATOPROTECTANTS: A NOVEL APPROACH TO PREVENT HEPATOTOXICITY DUE TO ANTITUBERCULOSIS TREATMENT

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 3

Abstract

The first line antituberculosis drugs, isoniazid, rifampicin and pyrazinamide continue to be the effective in the treatment of tuberculosis; however, their use is associated with toxic reactions in tissues, particularly in the liver, leading to hepatitis. Hepatotoxicity has been reported in Indian patients at a high risk (up to 11.5%) than in their western counterpart (up to 4.3%). Since all the drugs used in the treatment of tuberculosis are shown to have hepatotoxic effects, studies have been performed to prevent or reduce the toxicity by the use of natural herbal drugs without interfering with the therapeutic actions of the drugs. Management of liver disease is still a challenge to the modern medicine. In the absence of reliable liver-protective drugs in the allopathic medical practices, herbs play a vital role in the management of liver disorders. In traditional medicine, the plants have been used to cure jaundice. In Indian ayurvedic medicine, the oral administration of extracts of dried rhizomes and roots are claimed as a cure for human viral hepatitis. The present review summarizes the list of plants/herbal formulations studied for their hepatoprotective activity in antitubercular drugs-induced hepatitis. However, despite extensive positive research data from experimental studies for herbal drugs in antitubercular drugs-induced hepatitis, and a clinical study, large scale clinical trials are needed to explore the hepotoprotective potential of herbal medicines in antitubercular drugs-induced hepatotoxicity.

Authors and Affiliations

Vinay Kumar*| Assistant Professor & Head, Department of Pharmacology, KIET School of Pharmacy, Ghaziabad, U.P., India, Ankur Sharma| M. Pharm. Research Scholar, Department of Pharmacology, KIET School of Pharmacy, Ghaziabad, U.P., India, Lalit Machawal| Department of Pharmacology, Panjab University, Chandigarh, Punjab, India, Ahmed Abdullah Khan| M. Pharm. Research Scholar, Department of Pharmacology, KIET School of Pharmacy, Ghaziabad, U.P., India.

Keywords

Related Articles

AN OVERVIEW ON LAGENARIA SICERARIA (BOTTLE GOURD)

Cucurbitaceae family is a major source of medicinal agents’ science ancient times. Various plants parts including fruits of this family have been established for their pharmacological effect. Lagenaria siceraria (Molina)...

HYPEROSMOLALITY ALTERS MACROPHAGE SYNTHESIS AND REGULATION; ROLE OF PHOSPHOLIPASE C ENZYMES

High NaCl stimulates activity of the osmoprotective transcription factor TonEBP/OREBP by enhancing its phosphorylation, transactivating ability, and localization to the nucleus. PLC γ plays an important role in these mec...

PREVALENCE OF NON-FERMENTING GRAM NEGATIVE BACILLI FROM CLINICAL ISOLATES AND THEIR ANTIBIOGRAM PROFILE

Background and Objectives: Non fermenting gram negative bacilli (NFGNB) are an increasing cause of concern in the hospitals as they produce a therapeutic dilemma for the treating physician.The present study was undertake...

OXIDATIVE STRESS, ANTIOXIDANT STATUS AND 5’-NUCLEOTIDASE ACTIVITY IN CHRONIC HEPATITIS C AND ALCOHOLIC PATIENTS

Background: The present study was undertaken to estimate the 5’-nucleotidase enzyme in chronic hepatitis C and alcoholics. The oxidative stress, antioxidants and their correlation with 5’-nucleotidase was also included i...

The Comparsion of Piperacillin / Tazobactem with Clindamycin in Diabetic Foot Ulcers

To evaluate and compare the study and efficacy of piperacillin/tazobactem with clindamycin in diabetic foot ulcer according to Wagner’s different grades of classification of diabetic foot ulcer. The study was conducted...

Download PDF file
  • EP ID EP1751
  • DOI -
  • Views 419
  • Downloads 22

How To Cite

Vinay Kumar*, Ankur Sharma, Lalit Machawal, Ahmed Abdullah Khan (2013). BENEFICIAL ROLE OF HERBAL HEPATOPROTECTANTS: A NOVEL APPROACH TO PREVENT HEPATOTOXICITY DUE TO ANTITUBERCULOSIS TREATMENT. Journal of Biomedical and Pharmaceutical Research, 2(3), 181-193. https://europub.co.uk/articles/-A-1751